Literature DB >> 8567090

Cadmium in kidneys in Swedes measured in vivo using X-ray fluorescence analysis.

U Nilsson1, A Schütz, S Skerfving, S Mattsson.   

Abstract

An X-ray fluorescence (XRF) technique using plane polarized X-rays for excitation was used for in vivo measurements of cadmium in the kidney cortex among non-occupationally exposed members of the general population in southern Sweden. The measured concentrations of cadmium in the kidney cortex of smokers (median 28 micrograms/g, n = 10) were significantly higher (P = 0.0036) as compared to those in non-smokers (median 8 micrograms/g, n = 10), and so were the cadmium concentrations in blood and urine. The results show that smoking considerably increases the cadmium concentration in the kidney cortex and that smoking is a major source of cadmium exposure in the general population of Sweden. Except in the presence of very deeply situated kidneys, where the minimum detectable concentration is high, non-invasive in vivo XRF analysis of kidney cadmium should be a useful tool for evaluating the effects of long-term low-level exposure to cadmium and the risk of kidney damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567090     DOI: 10.1007/bf00381053

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  18 in total

1.  Cadmium metabolism in man.

Authors:  H Welinder; S Skerfving; O Henriksen
Journal:  Br J Ind Med       Date:  1977-08

2.  Distribution and concentration of cadmium in human kidney.

Authors:  M Svartengren; C G Elinder; L Friberg; B Lind
Journal:  Environ Res       Date:  1986-02       Impact factor: 6.498

3.  Conceptual problems in establishing the critical concentration of cadmium in human kidney cortex.

Authors:  T Kjellström; C G Elinder; L Friberg
Journal:  Environ Res       Date:  1984-04       Impact factor: 6.498

4.  In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine.

Authors:  H A Roels; R R Lauwerys; J P Buchet; A Bernard; D R Chettle; T C Harvey; I K Al-Haddad
Journal:  Environ Res       Date:  1981-10       Impact factor: 6.498

5.  Cadmium in man measured in vivo by x-ray fluorescence analysis.

Authors:  L Ahlgren; S Mattsson
Journal:  Phys Med Biol       Date:  1981-01       Impact factor: 3.609

6.  Cadmium: in vivo measurement in smokers and nonsmokers.

Authors:  K J Ellis; D Vartsky; I Zanzi; S H Cohn; S Yasumura
Journal:  Science       Date:  1979-07-20       Impact factor: 47.728

7.  Polarised X-rays in XRF-analysis for improved in vivo detectability of cadmium in man.

Authors:  J O Christoffersson; S Mattsson
Journal:  Phys Med Biol       Date:  1983-10       Impact factor: 3.609

8.  Cadmium in kidney cortex, liver, and pancreas from Swedish autopsies. Estimation of biological half time in kidney cortex, considering calorie intake and smoking habits.

Authors:  C G Elinder; B Lind; T Kjellström; L Linnman; L Friberg
Journal:  Arch Environ Health       Date:  1976 Nov-Dec

9.  Effect of acid precipitation on retention and excretion of elements in man.

Authors:  I Bensryd; L Rylander; B Högstedt; P Aprea; I Bratt; C Fåhraéus; A Holmén; A Karlsson; A Nilsson; B L Svensson
Journal:  Sci Total Environ       Date:  1994-05-02       Impact factor: 7.963

10.  Lead and cadmium levels in blood samples from the general population of Sweden.

Authors:  C G Elinder; L Friberg; B Lind; M Jawaid
Journal:  Environ Res       Date:  1983-02       Impact factor: 6.498

View more
  2 in total

1.  In vivo analysis of cadmium in battery workers versus measurements of blood, urine, and workplace air.

Authors:  J Börjesson; T Bellander; L Järup; C G Elinder; S Mattsson
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

2.  Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors.

Authors:  L Barregård; C Svalander; A Schütz; G Westberg; G Sällsten; I Blohmé; J Mölne; P O Attman; P Haglind
Journal:  Environ Health Perspect       Date:  1999-11       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.